211 related articles for article (PubMed ID: 22751663)
1. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
Nord CE; Lindmark A; Persson I
J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
[TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698.
Lofland D; Difuntorum S; Waller A; Clements JM; Weaver MK; Karlowsky JA; Johnson K
J Antimicrob Chemother; 2004 Apr; 53(4):664-8. PubMed ID: 14973152
[TBL] [Abstract][Full Text] [Related]
5. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
7. Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.
Min S; Ingraham K; Huang J; McCloskey L; Rilling S; Windau A; Pizzollo J; Butler D; Aubart K; Miller LA; Zalacain M; Holmes DJ; O'Dwyer K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4644-52. PubMed ID: 26014938
[TBL] [Abstract][Full Text] [Related]
8. Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections.
Spletstoser JT; Dreabit J; Knox AN; Benowitz A; Campobasso N; Ward P; Cui G; Lewandowski T; McCloskey L; Aubart KM
Bioorg Med Chem Lett; 2019 Aug; 29(16):2410-2414. PubMed ID: 31160176
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
[TBL] [Abstract][Full Text] [Related]
10. Peptide deformylase inhibitors with activity against respiratory tract pathogens.
East SP; Beckett RP; Brookings DC; Clements JM; Doel S; Keavey K; Pain G; Smith HK; Thomas W; Thompson AJ; Todd RS; Whittaker M
Bioorg Med Chem Lett; 2004 Jan; 14(1):59-62. PubMed ID: 14684298
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries.
Lee MY; Ko KS; Oh WS; Park S; Lee JY; Baek JY; Suh JY; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2006 Jul; 28(1):14-8. PubMed ID: 16777383
[TBL] [Abstract][Full Text] [Related]
12. Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
Apfel C; Banner DW; Bur D; Dietz M; Hirata T; Hubschwerlen C; Locher H; Page MG; Pirson W; Rossé G; Specklin JL
J Med Chem; 2000 Jun; 43(12):2324-31. PubMed ID: 10882358
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
14. Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity.
Axten JM; Medina JR; Blackledge CW; Duquenne C; Grant SW; Bobko MA; Peng T; Miller WH; Pinckney T; Gallagher TF; Kulkarni S; Lewandowski T; Van Aller GS; Zonis R; Ward P; Campobasso N
Bioorg Med Chem Lett; 2012 Jun; 22(12):4028-32. PubMed ID: 22579486
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322.
O'Dwyer K; Hackel M; Hightower S; Hoban D; Bouchillon S; Qin D; Aubart K; Zalacain M; Butler D
Antimicrob Agents Chemother; 2013 May; 57(5):2333-42. PubMed ID: 23478958
[TBL] [Abstract][Full Text] [Related]
16. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of nine peptide deformylase inhibitors and five comparator agents against respiratory and skin pathogens.
Bowker KE; Noel AR; MacGowan AP
Int J Antimicrob Agents; 2003 Dec; 22(6):557-61. PubMed ID: 14659651
[TBL] [Abstract][Full Text] [Related]
18. Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.
Smith KJ; Petit CM; Aubart K; Smyth M; McManus E; Jones J; Fosberry A; Lewis C; Lonetto M; Christensen SB
Protein Sci; 2003 Feb; 12(2):349-60. PubMed ID: 12538898
[TBL] [Abstract][Full Text] [Related]
19. [The antimicrobial activity of fluoroquinolone agents against pathogenic organisms in respiratory tract infections and its clinical effect].
Akiyama M; Takahashi A; Nagatake T; Yamashita H; Yoshida T; Rikitomi N; Ohishi K; Tanaka H; Morito T; Utsunomiya Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1174-81. PubMed ID: 2176251
[TBL] [Abstract][Full Text] [Related]
20. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
